The Strategic Shift  For most global Cosmetic brands, India's regulatory journey has begun with import registration — the COS-2 pathway explored throughout this series. But for a growing cohort of global Manufacturers,...

Regulatory approval is often treated as the finish line. In reality, for Medical Device and IVD manufacturers in India, it marks the start of an equally demanding obligation: Post-Market Surveillance (PMS). Under...

One of the most avoidable and expensive mistakes in Medical Device commercialisation is Regulatory rework — the process of going back to redo documentation, testing, or submissions  because the original data was...

Blood and Plasma-derived Medicinal products (PDMPs) — including immunoglobulins, albumin, clotting factors, and hyperimmune globulins — occupy a critical and highly regulated niche in India's healthcare system. These products are lifesaving for...

Drug approval is the beginning of a Pharmaceutical company's regulatory obligation — not its culmination. Once a product receives marketing approval, an extensive and ongoing set of post-marketing requirements comes into effect:...

Introduction: Why Applications Stall CliniExperts has managed Cosmetic Import registrations across 30+ countries of origin and 350+ product types. In that experience, the majority of query and application delays are caused by...